PTIX Protagenic Therapeutics, Inc.
$0.36
Protagenic Therapeutics, Inc. (PTIX) is expected to report earnings on November 13, 2026, after the market close.
Protagenic Therapeutics Reported Earnings
Earnings Date
Nov 13
Friday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.
Sector
Healthcare
Industry
Biotechnology